3 ASX shares I would buy and hold for the next decade

Blackmores Limited (ASX:BKL) is one of three ASX shares which I believe would make great buy and hold investments today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Legendary investor Warren Buffett didn't get where he is today by day trading. He accumulated his estimated US$64.8 billion wealth slowly and methodically through smart buy and hold investments.

I believe that buying shares with strong long-term growth prospects at a reasonable price and then holding tight to them is a great way for investors to produce returns which build up their wealth slowly and surely.

In my opinion the following three shares represent great buy and hold investments today:

Blackmores Limited (ASX: BKL)

As the health supplements company's shares are down 45% year to date, there might not be a better time to start a long-term investment in Blackmores. Valuation concerns and the prospect of a weak first quarter are largely to blame for the declines which have left its shares changing hands at just 17x estimated FY 2017 earnings. Although the first quarter is expected to be weak due to retailers destocking, management is confident that sales will pick up as the year goes by. Whilst the China market is likely to be the key driver of growth, it's certainly not going to be the only one. Blackmores has recently announced its intention to expand into the potentially lucrative Iran market.

Mayne Pharma Group Ltd (ASX: MYX)

I believe Adelaide-based Mayne Pharma has the potential to become a pharmaceutical giant in the next decade. This is thanks largely to the portfolio of drugs it recently acquired from industry behemoths giants Teva Pharmaceuticals and Allergan. Management has advised that it expects this acquisition to be significantly accretive to earnings in FY 2017, which should go some way to helping Mayne Pharma continue its impressive growth. In FY 2016 the company delivered a massive 379% increase in full year net profit after tax.

Ramsay Health Care Limited (ASX: RHC)

Although it may be a little on the expensive side at 30x estimated FY 2017 earnings, I believe this private hospital operator is worth paying a premium to own. With the number of people worldwide aged over 60 expected to triple by 2050, I expect that demand for its 221 hospitals across six countries will remain strong for decades. The company also has its eyes on the China market. Whilst it may have pulled out of a joint venture there this year, I don't believe it will be too long before we see Ramsay operating in the world's second-largest economy.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »